CureVac N.V.
CVAC
$3.41
$0.051.49%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
5/5/2025
-
MarketBeat
5/2/2025
-
MarketBeat
5/2/2025
-
Tickeron - Technical Analysis
5/1/2025
-
Simply Wall St
4/30/2025
-
MarketBeat
4/30/2025
-
GuruFocus
4/30/2025
-
The Fly
4/30/2025
-
Tickeron - Stocks
4/27/2025
-
MarketBeat
4/23/2025
-
MarketBeat
4/22/2025
-
Zolmax
4/17/2025
-
Zacks Investment Research
4/17/2025
-
MarketBeat
4/15/2025
-
ETF Channel
4/14/2025
-
MarketBeat
4/14/2025
-
Simply Wall St
4/13/2025
-
Simply Wall St
4/12/2025
-
Insider Monkey
4/12/2025
-
TipRanks Financial Blog
4/11/2025
-
GuruFocus
4/11/2025
-
GuruFocus
4/11/2025
-
TipRanks Financial Blog
4/11/2025
-
TipRanks Financial Blog
4/10/2025
-
Seeking Alpha: Transcripts
4/10/2025
-
SeekingAlpha
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Friday, April 11, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 19 and 23 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
49 7071 9883 0
Address
Friedrich-Miescher-Strasse 15
Tübingen, 72076
Tübingen, 72076
Country
Year Founded
Business Description
Sector
CureVac N.V., a biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). The company’s portfolio includes clinical and...
more